Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Javier Perez-Contreras"'
Autor:
Antonio Franco, Patricio Más-Serrano, Noelia Balibrea, David Rodriguez, Aurora Javaloyes, Marcos Díaz, Isabel Gascón, Amelia Ramon-Lopez, Javier Perez-Contreras, Juan Selva, Ricardo Nalda-Molina
Publikováno v:
Nefrología, Vol 39, Iss 5, Pp 506-512 (2019)
Resumen: El objetivo del presente estudio fue evaluar las concentraciones valle (Cpvalle) y la pauta posológica de tacrolimus tras la conversión de Prograf o Advagraf a Envarsus (nueva forma farmacéutica con tecnología Meltdose que mejora la abso
Externí odkaz:
https://doaj.org/article/1b48f1b35979460691cef97f0caf4677
Autor:
Antonio Franco, Patricio Más-Serrano, Noelia Balibrea, David Rodriguez, Aurora Javaloyes, Marcos Díaz, Isabel Gascón, Amelia Ramon-Lopez, Javier Perez-Contreras, Juan Selva, Ricardo Nalda-Molina
Publikováno v:
Nefrología (English Edition), Vol 39, Iss 5, Pp 506-512 (2019)
The aim of this study was to evaluate the trough concentrations (Cptrough) and the tacrolimus dosage regimen after the conversion of Prograf or Advagraf to Envarsus (new pharmaceutical form with MeltDose technology that improves the absorption of fat
Externí odkaz:
https://doaj.org/article/f5738a702a174f7d839e1d1a274a5186
Autor:
Antonio Franco Esteve, Patricio Mas-Serrano, Fransico Manuel Marco, Eduardo Garin Cascales, Francisco Javier Perez Contreras
Publikováno v:
Transplantology, Vol 5, Iss 1, Pp 37-45 (2024)
There is uncertainty about the best approach to replacement treatment for kidney transplant recipients with chronic terminal graft dysfunction, since a retransplant could be performed before the resumption of dialysis, thus avoiding this treatment an
Externí odkaz:
https://doaj.org/article/e2c296400066454a88467fa5a5055266
Autor:
Isabel Gascón, Amelia Ramon-Lopez, Javier Perez-Contreras, Juan Selva, Ricardo Nalda-Molina, Patricio Más-Serrano, Marcos Díaz, Noelia Balibrea, David Jiménez Rodríguez, Aurora Javaloyes, Antonio Franco
Publikováno v:
Nefrología, Vol 39, Iss 5, Pp 506-512 (2019)
Resumen: El objetivo del presente estudio fue evaluar las concentraciones valle (Cpvalle) y la pauta posológica de tacrolimus tras la conversión de Prograf o Advagraf a Envarsus (nueva forma farmacéutica con tecnología Meltdose que mejora la abso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a370b0fabd5d0649146bdf1fe6f1c6
https://doi.org/10.1016/j.nefro.2018.11.009
https://doi.org/10.1016/j.nefro.2018.11.009
Autor:
Noelia Balibrea, Antonio Franco, Amelia Ramon-Lopez, Ricardo Nalda-Molina, Aurora Javaloyes, Isabel Gascón, David Jiménez Rodríguez, Patricio Más-Serrano, Marcos Díaz, Javier Perez-Contreras, Juan Selva
Publikováno v:
Nefrología (English Edition), Vol 39, Iss 5, Pp 506-512 (2019)
The aim of this study was to evaluate the trough concentrations (Cptrough) and the tacrolimus dosage regimen after the conversion of Prograf or Advagraf to Envarsus (new pharmaceutical form with MeltDose technology that improves the absorption of fat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4e4f2c2e11c6d1acb0de6950d42e8a
http://www.sciencedirect.com/science/article/pii/S2013251419301397
http://www.sciencedirect.com/science/article/pii/S2013251419301397
Publikováno v:
Nucleosides, nucleotidesnucleic acids. 40(7)
Hemodialysis adequately controls serum uric acid (UA) levels, making UA-lowering drugs unnecessary; scant data are available for peritoneal dialysis (PD). We analyzed blood, 24 h urine and dialysis fluid from twenty patients under PD, to assess UA le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a75792ef87ab82439c718338ecfc9b6
https://pubmed.ncbi.nlm.nih.gov/34085590
https://pubmed.ncbi.nlm.nih.gov/34085590
Autor:
Edwina A. Brown, George J Mellote, Renzo Scanziani, Olof Heimbürger, Simon J. Davies, Jose C. Divino Filho, Werner Reigel, Javier Perez-Contreras, Dirk Kuypers, Christian D'Auzac, Elaine J. Clutterbuck, Nicanor Vega Diaz
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 26:458-465
Background Primary analysis of the European Automated Peritoneal Dialysis Outcomes Study (EAPOS) found that patients with daily ultrafiltration (UF) below a predefined target of 750 mL at baseline experienced increased mortality and continuing low UF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1633258df4337e250fa1db565b4cbf3
https://doi.org/10.1177/089686080602600410
https://doi.org/10.1177/089686080602600410
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 23:403-405
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbea6e8e5b9ed50a2ed9cd325991089d
https://doi.org/10.1177/089686080302300417
https://doi.org/10.1177/089686080302300417
Autor:
Simon J, Davies, Edwina A, Brown, Werner, Reigel, Elaine, Clutterbuck, Olof, Heimbürger, Nicanor Vega, Diaz, George J, Mellote, Javier, Perez-Contreras, Renzo, Scanziani, Christian, D'Auzac, Dirk, Kuypers, Jose C, Divino Filho
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 26(4)
Primary analysis of the European Automated Peritoneal Dialysis Outcomes Study (EAPOS) found that patients with daily ultrafiltration (UF) below a predefined target of 750 mL at baseline experienced increased mortality and continuing low UF over 2 yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6c0389b1ee0bb23e9ca746454d98726e
https://pubmed.ncbi.nlm.nih.gov/16881341
https://pubmed.ncbi.nlm.nih.gov/16881341